A new clinical trial map is now accessible from the public website of the Clinical Trials Information System (CTIS), the European Medicines Agency (EMA) said.
The map is designed to provide patients and healthcare professionals easy access to comprehensive, real-time information about clinical trials conducted in their area, thereby increasing access to clinical research in the European Union (EU).
Building on the public information contained in CTIS, the map makes it easier to find information about clinical trials. Users can look for ongoing trials by geographic area and medical condition. The search supports queries in lay language and includes an autocorrect system that provides suggestions in case of misspelling. Search results offer investigator’s contact details, enabling members of the public to directly enquire about potential enrolment in a given trial. The first version of the map is in English. More EU languages will be added in future releases.
The map is part of the Accelerating Clinical Trials in the European Union (ACT EU) initiative’s work plan for 2025-26. It is in response to requests for a simple, patient-friendly CTIS dashboard to help stakeholders, particularly patients, locate clinical trials of interest in Europe. EMA recently hosted a public webinar to demonstrate the usage of the various features of the map; a recording will be available for future use.
CTIS offers a public searchable database for healthcare professionals, patients and citizens to ensure a high level of transparency, as envisaged by the Clinical Trials Regulation. The authorisation and oversight of clinical trials is the responsibility of EU/EEA (European Economic Area) member states, while EMA is responsible for maintaining CTIS. The European Commission oversees the implementation of the Clinical TrialsRegulation.
(Source: EMA)
